Unio Capital LLC Has $14.13 Million Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Unio Capital LLC has reduced its stake in Intuitive Surgical, Inc. by 2.4%, making it the firm's 10th largest position, with remaining shares valued at approximately $14.1 million.
• Several institutional investors have increased their holdings in Intuitive Surgical, with 83.64% of the stock now owned by hedge funds and other institutional investors.
• Analysts maintain a positive outlook on the stock, with the consensus target price set at $595.95 and a majority rating it as a "Buy" based on recent earnings performance and upgrades.

Unio Capital LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,535 shares of the medical equipment provider's stock after selling 699 shares during the quarter. Intuitive Surgical accounts for about 5.4% of Unio Capital LLC's holdings, making the stock its 10th biggest position. Unio Capital LLC's holdings in Intuitive Surgical were worth $14,133,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. AlphaCore Capital LLC raised its holdings in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after buying an additional 18 shares during the last quarter. Second Line Capital LLC raised its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the last quarter. Crown Wealth Group LLC raised its holdings in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after buying an additional 20 shares during the last quarter. FSM Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after buying an additional 20 shares during the last quarter. Finally, CFO4Life Group LLC raised its holdings in shares of Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 over the last 90 days. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on ISRG shares. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. UBS Group increased their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $17.56 on Wednesday, reaching $449.98. 2,558,133 shares of the stock were exchanged, compared to its average volume of 2,023,260. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a market cap of $161.31 billion, a PE ratio of 62.76, a P/E/G ratio of 4.93 and a beta of 1.61. The stock has a 50 day moving average price of $491.12 and a 200 day moving average price of $510.92.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the business posted $1.78 earnings per share. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.